Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of GW685698X nasal spray in perennial allergic rhinitis
2004-000091-14Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate in perennial rhinitis (2 arms), sponsored by GSK. Primary endpoint: Primary safety endpoint. Started Jun 2004; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on 2004-000091-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000091-14.